FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefano Ruggieri

Research Profile

Disorders

Parkinson's Disease

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Ubaldo Bonuccelli; Carlo Caltagirone; Roberto Ceravolo; Grazia Dell'Agnello; Giovanni Fabbrini; Michele Guadagna; Laura Avanzino; Giuseppe Meco; Francesca Morgante; Mariangela Pierantozzi; Andrea Rossi; Stefano Ruggieri; Mauro Silvestrini; Riccardo Spezia; Fabrizio Stocchi; Alessandro Tessitore; Michele Mancini
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
Francesca Di Biasio; Alfonso Fasano; Barbara Gandolfi; Giovanni Grillea; Francesco Lena; Nicola Modugno; Sara Pietracupa; Giovanni Caranci; Nicola Vanacore; Stefano Ruggieri
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
Gianfranco Natale; Olga Kastsiushenka; Federica Fulceri; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefano Ruggieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ubaldo Bonuccelli; Carlo Caltagirone; Roberto Ceravolo; Grazia Dell'Agnello; Giovanni Fabbrini; Michele Guadagna; Laura Avanzino; Giuseppe Meco; Francesca Morgante; Mariangela Pierantozzi; Andrea Rossi; Stefano Ruggieri; Mauro Silvestrini; Riccardo Spezia; Fabrizio Stocchi; Alessandro Tessitore; Michele Mancini
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
Expert opinion on pharmacotherapy 2012;13(16):2269-80.
2012: Francesca Di Biasio; Alfonso Fasano; Barbara Gandolfi; Giovanni Grillea; Francesco Lena; Nicola Modugno; Sara Pietracupa; Giovanni Caranci; Nicola Vanacore; Stefano Ruggieri
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(5):597-604.
2010: Gianfranco Natale; Olga Kastsiushenka; Federica Fulceri; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut.
Brain research 2010;1355():195-206.
2010: Gabriele Siciliano; C Carlesi; Livia Pasquali; S Piazza; S Pietracupa; Francesco Fornai; Stefano Ruggieri; Luigi Murri
Clinical trials for neuroprotection in ALS.
CNS & neurological disorders drug targets 2010;9(3):305-13.
2009: Livia Pasquali; Stefano Ruggieri; Luigi Murri; Antonio Paparelli; Francesco Fornai
Does autophagy worsen or improve the survival of dopaminergic neurons?
Parkinsonism & related disorders 2009;15 Suppl 4():S24-7.
2009: Livia Pasquali; Patrizia Longone; Ciro Isidoro; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Autophagy, lithium, and amyotrophic lateral sclerosis.
Muscle & nerve 2009;40(2):173-94.
2009: Francesco Fornai; Francesca Biagioni; Federica Fulceri; Luigi Murri; Stefano Ruggieri; Antonio Paparelli
Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.
International review of neurobiology 2009;88():371-98.
2008: Gianfranco Natale; Olga Kastsiuchenka; Livia Pasquali; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
Annals of the New York Academy of Sciences 2008;1139():345-9.
2008: Riccardo Ruffoli; Paola Soldani; Livia Pasquali; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Methamphetamine fails to alter the noradrenergic integrity of the heart.
Annals of the New York Academy of Sciences 2008;1139():337-44.
2008: Livia Pasquali; Gloria Lazzeri; Ciro Isidoro; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Role of autophagy during methamphetamine neurotoxicity.
Annals of the New York Academy of Sciences 2008;1139():191-6.
2008: Paola Lenzi; Federica Fulceri; Gloria Lazzeri; Alessandro Casini; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Analysis of single, purified inclusions as a novel approach to understand methamphetamine neurotoxicity.
Annals of the New York Academy of Sciences 2008;1139():186-90.
2008: Michela Ferrucci; Livia Pasquali; Antonio Paparelli; Stefano Ruggieri; Francesco Fornai
Pathways of methamphetamine toxicity.
Annals of the New York Academy of Sciences 2008;1139():177-85.
2008: Francesco Fornai; Patrizia Longone; Michela Ferrucci; Paola Lenzi; Ciro Isidoro; Stefano Ruggieri; Antonio Paparelli
Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium.
Autophagy 2008;4(4):527-30.
2008: Francesco Fornai; Gabriele Siciliano; Maria Laura Manca; Luigi Murri; Antonio Paparelli; Stefano Ruggieri
Lithium in ALS: from the bench to the bedside.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(2):123-4.
2008: Francesco Fornai; Patrizia Longone; Luisa Cafaro; Olga Kastsiuchenka; Michela Ferrucci; Maria Laura Manca; Gloria Lazzeri; Alida Spalloni; Natascia Bellio; Paola Lenzi; Nicola Modugno; Gabriele Siciliano; Ciro Isidoro; Luigi Murri; Stefano Ruggieri; Antonio Paparelli
Lithium delays progression of amyotrophic lateral sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(6):2052-7.
2008: Michela Ferrucci; Livia Pasquali; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Alpha-synuclein and autophagy as common steps in neurodegeneration.
Parkinsonism & related disorders 2008;14 Suppl 2():S180-4.
2007: Giada Frenzilli; Michela Ferrucci; Filippo S Giorgi; Fabio Blandini; Marco Nigro; Stefano Ruggieri; Luigi Murri; Antonio Paparelli; Francesco Fornai
DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
Behavioural pharmacology 2007;18(5-6):471-81.
2007: Federica Fulceri; Francesca Biagioni; Michela Ferrucci; Gloria Lazzeri; A Bartalucci; V Galli; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.
Brain research 2007;1135(1):219-29.
2007: Francesco Fornai; Paola Lenzi; Gloria Lazzeri; Michela Ferrucci; Federica Fulceri; Filippo S Giorgi; Alessandra Falleni; Stefano Ruggieri; Antonio Paparelli
Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
Brain research 2007;1129(1):174-90.
2007: Francesco Fornai; Riccardo Ruffoli; Paola Soldani; Stefano Ruggieri; Antonio Paparelli
The "Parkinsonian heart": from novel vistas to advanced therapeutic approaches in Parkinson's disease.
Current medicinal chemistry 2007;14(23):2421-8.
2007: Francesco Fornai; Adolfo Bandettini Di Poggio; Antonio Pellegrini; Stefano Ruggieri; Antonio Paparelli
Noradrenaline in Parkinson's disease: from disease progression to current therapeutics.
Current medicinal chemistry 2007;14(22):2330-4.
2006: Luisa Iacovelli; Federica Fulceri; Antonio De Blasi; Ferdinando Nicoletti; Stefano Ruggieri; Francesco Fornai
The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
Experimental neurology 2006;201(1):24-31.
2006: Filippo S Giorgi; Gloria Lazzeri; Gianfranco Natale; Alfonso Iudice; Stefano Ruggieri; Antonio Paparelli; Luigi Murri; Francesco Fornai
MDMA and seizures: a dangerous liaison?
Annals of the New York Academy of Sciences 2006;1074():357-64.
2006: Federica Fulceri; Francesca Biagioni; Paola Lenzi; Alessandra Falleni; Marco Gesi; Stefano Ruggieri; Francesco Fornai
Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
Annals of the New York Academy of Sciences 2006;1074():344-8.
2006: Francesca Biagioni; Carla L Busceti; Gemma Molinaro; Giuseppe Battaglia; Filippo S Giorgi; Stefano Ruggieri; Francesco Fornai
Dopamine stimulation via infusion in the lateral ventricle.
Annals of the New York Academy of Sciences 2006;1074():337-43.
2006: Marco Gesi; Gloria Lazzeri; Michela Ferrucci; Antonio Pellegrini; Paola Lenzi; Stefano Ruggieri; Francesco Fornai; Antonio Paparelli
Inclusion dynamics in PC12 is comparable between amphetamines and MPTP.
Annals of the New York Academy of Sciences 2006;1074():315-9.
2006: Gloria Lazzeri; Paola Lenzi; Marco Gesi; Michela Ferrucci; Federica Fulceri; Stefano Ruggieri; Valeria Bruno; Francesco Fornai
In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition.
Annals of the New York Academy of Sciences 2006;1074():174-7.
2006: Michela Ferrucci; Carla L Busceti; Alessandra Falleni; Filippo S Giorgi; Stefano Ruggieri; Francesco Fornai
Effects of methamphetamine on the cerebellar cortex: a preliminary study.
Annals of the New York Academy of Sciences 2006;1074():149-53.
2006: Francesco Fornai; Gloria Lazzeri; Adolfo Bandettini di Poggio; Paola Soldani; Antonio De Blasi; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
Annals of the New York Academy of Sciences 2006;1074():84-9.
2006: Filippo S Giorgi; Giuseppe Mauceli; Fabio Blandini; Stefano Ruggieri; Antonio Paparelli; Luigi Murri; Francesco Fornai
Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy.
Epilepsia 2006;47 Suppl 5():21-5.
2006: Filippo S Giorgi; Adolfo Bandettini di Poggio; Giuseppe Battaglia; Antonio Pellegrini; Luigi Murri; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(70):105-9.
2005: Francesco Fornai; Paola Lenzi; Michela Ferrucci; Gloria Lazzeri; Adolfo Bandettini Di Poggio; Gianfranco Natale; Carla L Busceti; Francesca Biagioni; Mario Giusiani; Stefano Ruggieri; Antonio Paparelli
Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Brain research bulletin 2005;65(5):405-13.
2005: Francesco Fornai; Paola Soldani; Gloria Lazzeri; Adolfo Bandettini Di Poggio; Francesca Biagioni; Federica Fulceri; Serena Batini; Stefano Ruggieri; Antonio Paparelli
Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
Brain research bulletin 2005;65(4):275-90.
2005: Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(9):3413-8.
2004: Francesco Fornai; Marco Gesi; Paola Lenzi; Michela Ferrucci; Gloria Lazzeri; Chiara Pizzanelli; Antonio Pellegrini; Giuseppe Battaglia; Stefano Ruggieri; Antonio Paparelli
Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry.
Annals of the New York Academy of Sciences 2004;1025():181-8.
2004: Francesco Fornai; Paola Lenzi; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Loredana Capobianco; Antonio De Blasi; Giuseppe Battaglia; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli
Similarities between methamphetamine toxicity and proteasome inhibition.
Annals of the New York Academy of Sciences 2004;1025():162-70.
2004: Alessandra Monge; Fabio Viselli; Fabrizio Stocchi; Luca Barbato; Andrea Bolner; Nicola Modugno; Michele Paradiso; Stefano Ruggieri; Gianpietro Nordera
Variation in the dopaminergic response during the day in Parkinson disease.
Clinical neuropharmacology 2004;27(3):116-8.
2004: Francesco Fornai; Paola Lenzi; Giada Frenzilli; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Francesca Biagioni; Marco Nigro; Alessandra Falleni; Mario Giusiani; Antonio Pellegrini; Fabio Blandini; Stefano Ruggieri; Antonio Paparelli
DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).
Psychopharmacology 2004;173(3-4):353-63.
2003: Francesco Fornai; Gloria Lazzeri; Paola Lenzi; Marco Gesi; Michela Ferrucci; Paola Soldani; Antonio Pellegrini; Loredana Capobianco; Antonio De Blasi; Stefano Ruggieri; Antonio Paparelli
Amphetamines induce ubiquitin-positive inclusions within striatal cells.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003;24(3):182-3.
2003: Francesco Fornai; Paola Lenzi; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Riccardo Ruffoli; Paola Soldani; Stefano Ruggieri; Maria G Alessandri; Antonio Paparelli
Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(26):8955-66.
2003: Giuseppe Battaglia; Carla L Busceti; Fabrizio Pontarelli; Francesca Biagioni; Francesco Fornai; Antonio Paparelli; Valeria Bruno; Stefano Ruggieri; Ferdinando Nicoletti
Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Neuropharmacology 2003;45(2):155-66.
2003: Francesco Fornai; Paola Lenzi; Marco Gesi; Michela Ferrucci; Gloria Lazzeri; Gianfranco Natale; Stefano Ruggieri; Antonio Paparelli
Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's disease.
Current drug targets. CNS and neurological disorders 2003;2(3):149-52.
2003: Fabrizio Stocchi; Alfredo Berardelli; Laura Vacca; Luca Barbato; Alessandra Monge; Gianpietro Nordera; Stefano Ruggieri
Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.
Clinical neuropharmacology 2003;26(3):151-5.
2002: Mara Cirone; Laura Cuomo; Claudia Zompetta; Stefano Ruggieri; Luigi Frati; Alberto Faggioni; Giuseppe Ragona
Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens.
Journal of medical virology 2002;68(2):268-72.
2002: Fabrizio Stocchi; Alfredo Berardelli; Laura Vacca; A Thomas; Maria Francesca De Pandis; Nicola Modugno; M Valente; Stefano Ruggieri
Combination of two different dopamine agonists in the management of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S115-6.
2002: Michela Ferrucci; Marco Gesi; Paola Lenzi; Paola Soldani; Riccardo Ruffoli; Antonio Pellegrini; Stefano Ruggieri; Antonio Paparelli; Francesco Fornai
Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23 Suppl 2():S75-6.
2002: Fabrizio Stocchi; Stefano Ruggieri; Laura Vacca; C Warren Olanow
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 9):2058-66.
2002: Francesco Fornai; Marco Gesi; Paola Lenzi; Michela Ferrucci; Antonio Pellegrini; Stefano Ruggieri; A Casini; Antonio Paparelli
Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration.
Annals of the New York Academy of Sciences 2002;965():381-98.
2002: Giuseppe Battaglia; Marco Gesi; Paola Lenzi; Carla L Busceti; Paola Soldani; Francesco Orzi; L Rampello; F Nicoletti; Stefano Ruggieri; Francesco Fornai
Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Annals of the New York Academy of Sciences 2002;965():254-66.
2002: Francesco Fornai; Carla L Busceti; Michela Ferrucci; Gloria Lazzeri; Stefano Ruggieri
Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia?
Functional neurology 2002;17(2):93-9.
2002: Giuseppe Battaglia; Carla L Busceti; Laura Cuomo; Filippo S Giorgi; Francesco Orzi; Antonio De Blasi; Ferdinando Nicoletti; Stefano Ruggieri; Francesco Fornai
Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
Neuropharmacology 2002;42(3):367-73.
2001: Nicola Modugno; Antonio Currà; Morena Giovannelli; Alberto Priori; F Squitieri; Stefano Ruggieri; Mario Manfredi; Alfredo Berardelli
The prolonged cortical silent period in patients with Huntington's disease.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(8):1470-4.
2001: Francesco Fornai; Giuseppe Battaglia; Marco Gesi; Francesco Orzi; Ferdinando Nicoletti; Stefano Ruggieri
Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage.
Brain research 2001;898(1):27-35.
2001: Fabrizio Stocchi; Laura Vacca; Alfredo Berardelli; F De Pandis; Stefano Ruggieri
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):301-5.
2001: Fabrizio Stocchi; Laura Vacca; Maria Francesca De Pandis; Luca Barbato; M Valente; Stefano Ruggieri
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22(1):93-4.
2001: Fabrizio Stocchi; Laura Vacca; M Valente; Stefano Ruggieri
Sleep disorders in Parkinson's disease.
Advances in neurology 2001;86():289-93.
2001: Brunella Caronti; Giovanni Antonini; Caterina Calderaro; Stefano Ruggieri; Guido Palladini; Francesco E Pontieri; Carlo Colosimo
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(7):803-7.
2000: Francesco Fornai; Giuseppe Battaglia; Marco Gesi; Filippo S Giorgi; Francesco Orzi; Ferdinando Nicoletti; Stefano Ruggieri
Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.
Brain research 2000;887(1):110-7.
2000: Fabrizio Stocchi; Danilo Badiali; Laura Vacca; L D'Alba; F Bracci; Stefano Ruggieri; M Torti; Alfredo Berardelli; Enrico Corazziari
Anorectal function in multiple system atrophy and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):71-6.
1999: Brunella Caronti; Gianluigi Tanda; Carlo Colosimo; Stefano Ruggieri; Caterina Calderaro; Guido Palladini; Francesco E Pontieri; GAETANO DI CHIARA
Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.
Neuroreport 1999;10(14):2907-10.
1999: Fabrizio Stocchi; C Farina; Gianpietro Nordera; Stefano Ruggieri
Implantable venous access system for apomorphine infusion in complicated Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):358.
1999: Fabrizio Stocchi; Enrico Corazziari; A Carbone; Laura Vacca; Maria Francesca De Pandis; Alfredo Berardelli; Stefano Ruggieri
Urinary and anorectal function evaluation in Parkinson's disease.
Advances in neurology 1999;80():347-51.
1998: B Mercuri; Alfredo Berardelli; Nicola Modugno; Laura Vacca; Stefano Ruggieri; Mario Manfredi
Reciprocal inhibition in forearm muscles in patients with essential tremor.
Muscle & nerve 1998;21(6):796-9.
1998: Fabrizio Stocchi; Luca Barbato; Gianpietro Nordera; Alfredo Berardelli; Stefano Ruggieri
Sleep disorders in Parkinson's disease.
Journal of neurology 1998;245 Suppl 1():S15-8.
1997: Luca Barbato; Fabrizio Stocchi; Alessandra Monge; Laura Vacca; Stefano Ruggieri; Gianpietro Nordera; CD Marsden
The long-duration action of levodopa may be due to a postsynaptic effect.
Clinical neuropharmacology 1997;20(5):394-401.
1997: Stefano Ruggieri; Maria Francesca De Pandis; A Bonamartini; Laura Vacca; Fabrizio Stocchi
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
Clinical neuropharmacology 1997;20(3):204-9.
1997: Vito Margotta; Brunella Caronti; Giuseppe Meco; Angelo Merante; Stefano Ruggieri; Giorgio Venturini; Guido Palladini
Effects of cocaine treatment on the nervous system of planaria (Dugesia gonocephala s. l.). Histochemical and ultrastructural observations.
European journal of histochemistry : EJH 1997;41(3):223-30.
1996: Fabrizio Stocchi; Luca Barbato; L Bramante; Gianpietro Nordera; Laura Vacca; Stefano Ruggieri
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester.
Journal of neurology 1996;243(5):377-80.
1996: Fabrizio Stocchi; A Bonamartini; Laura Vacca; Stefano Ruggieri
Motor fluctuations in levodopa treatment: clinical pharmacology.
European neurology 1996;36 Suppl 1():38-42.
1996: Stefano Ruggieri; Giovanni Fabbrini; L Bramante; F DePandis; Fabrizio Stocchi; Piero Barbanti; Laura Vacca; Mario Manfredi
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
Advances in neurology 1996;69():595-8.
1996: Fabrizio Stocchi; A Carbone; M Inghilleri; D Frongillo; Luca Barbato; L Bramante; D Cannata; Mario Manfredi; Stefano Ruggieri
Instrumental diagnosis of multiple system atrophy.
Advances in neurology 1996;69():421-4.
1995: Giovanni Fabbrini; fabio baronti; Stefano Ruggieri; Gian Luigi Lenzi
Meningioma-induced loss of antiparkinsonian response to levodopa.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):231-2.
1995: D Frongillo; Fabrizio Stocchi; P Buccolini; P Stecconi; F Viselli; Stefano Ruggieri; D Cannata
Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy.
Fundamental & clinical pharmacology 1995;9(2):187-96.
1994: Fabrizio Stocchi; Luca Barbato; L Bramante; A Bonamartini; Stefano Ruggieri
The clinical efficacy of a single afternoon dose of levodopa methyl ester: a double-blind cross-over study versus placebo.
Functional neurology 1994;9(5):259-64.
1994: Luca Barbato; Steno Rinalduzzi; M Laurenti; Stefano Ruggieri; Neri Accornero
Color VEPs in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1994;92(2):169-72.
1994: Fabrizio Stocchi; Niall Quinn; Luca Barbato; P N Patsalos; M T O'Connel; Stefano Ruggieri; CD Marsden
Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1994;17(1):38-44.
1994: Fabrizio Stocchi; P N Patsalos; Alfredo Berardelli; Luca Barbato; A Bonamartini; Mario Manfredi; Stefano Ruggieri
Clinical implications of sustained dopaminergic stimulation.
Clinical neuropharmacology 1994;17 Suppl 2():S7-13.
1993: A Capria; A Attanasio; D Frongillo; Stefano Ruggieri; Fabrizio Stocchi
Transient left bundle branch block following intravenous lisuride bolus.
Fundamental & clinical pharmacology 1993;7(2):115-7.
1993: Fabrizio Stocchi; L Bramante; A Monge; F Viselli; fabio baronti; E Stefano; Stefano Ruggieri
Apomorphine and lisuride infusion. A comparative chronic study.
Advances in neurology 1993;60():653-5.
1993: Fabrizio Stocchi; Luca Barbato; A Carbone; Giovanni Fabbrini; Stefano Ruggieri; A Bonamartini; G Baffigo; A Agnoli
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Advances in neurology 1993;60():434-7.
1992: M J Steiger; Fabrizio Stocchi; L Bramante; Stefano Ruggieri; Niall Quinn
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.
Clinical neuropharmacology 1992;15(6):501-4.
1992: Fabrizio Stocchi; Stefano Ruggieri; A Carta; J Ryatt; Niall Quinn; Peter Jenner; CD Marsden; A Agnoli
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):249-56.
1991: Rita Formisano; Stefano Ruggieri; Rosanna Cerbo; F Lucarelli; G De Vuono; M Parmegiani; A Agnoli; A Attanasio; A Capria; C G Piccolo
Continuous intravenous infusion of TRH-T: clinical, cardiovascular and endocrinological effects.
Acta neurologica Scandinavica 1991;84(6):514-8.
1991: fabio baronti; Stefano Ruggieri; M Maral Mouradian; A Bonamartini; P Bocciarelli; Maria Francesca De Pandis; Thomas N Chase; A Agnoli
[Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease].
Rivista di neurologia 1991;61(6):210-4.
1991: Stefano Ruggieri; Fabrizio Stocchi; fabio baronti; F Viselli; R Horowski; C Lucarelli; A Agnoli
Antagonist effect of terguride in Parkinson's disease.
Clinical neuropharmacology 1991;14(5):450-6.
1991: M J Steiger; Fabrizio Stocchi; A Carta; Stefano Ruggieri; A Agnoli; Niall Quinn; CD Marsden
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.
Clinical neuropharmacology 1991;14(3):241-4.
1990: A Attanasio; A Capria; G Leggiadro; M Michisanti; D Cannata; Fabrizio Stocchi; Stefano Ruggieri
Transient cardiac arrest during continuous intravenous infusion of apomorphine.
Lancet 1990;336(8726):1321.
1989: Giorgio Venturini; Fabrizio Stocchi; Vito Margotta; Stefano Ruggieri; D Bravi; P Bellantuono; Guido Palladini
A pharmacological study of dopaminergic receptors in planaria.
Neuropharmacology 1989;28(12):1377-82.
1989: A Capria; A Attanasio; M Quatrana; D Cannata; Mario Fioravanti; Fabrizio Stocchi; Stefano Ruggieri
Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Clinical neuropharmacology 1989;12(4):331-8.
1989: Stefano Ruggieri; Fabrizio Stocchi; A Carta; M Bragoni; C Agostini; Luca Barbato; A Agnoli
One year treatment with lisuride delivery pump in Parkinson's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(1-2):173-83.
1988: Stefano Ruggieri; A Carta; Fabrizio Stocchi; Angelo Antonini; P Bellantuono; A Monge
Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
Functional neurology 1988;3(4):471-9.
1988: A Agnoli; Fabrizio Stocchi; A Carta; Angelo Antonini; M Bragoni; Stefano Ruggieri
Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
The Mount Sinai journal of medicine, New York 1988;55(1):62-6.
1988: Stefano Ruggieri; Fabrizio Stocchi; A Carta; D Bravi; M Bragoni; L Giorgi; A Agnoli
Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):313-9.
1988: Fabrizio Stocchi; Stefano Ruggieri; Angelo Antonini; fabio baronti; G Brughitta; P Bellantuono; D Bravi; A Agnoli
Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Journal of neural transmission. Supplementum 1988;27():27-33.
1987: Fabrizio Stocchi; Stefano Ruggieri; fabio baronti; P Bellantuono; G Brughita; Angelo Antonini; D Bravi; A Agnoli
[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].
La Clinica terapeutica 1987;122(2):83-8.
1987: A Capria; Fabrizio Stocchi; A Attanasio; M Quatrana; D Cannata; Stefano Ruggieri
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm.
Chest 1987;91(5):792-3.
1987: Alfredo Berardelli; Fabrizio Stocchi; M Gallucci; Stefano Ruggieri; Neri Accornero; A Agnoli; Mario Manfredi
Neurophysiological and magnetic resonance studies in a patient with hemiballismus.
Functional neurology 1987;2(1):93-8.
1986: Stefano Ruggieri; alessandro denaro; Giuseppe Meco; A Carta; Fabrizio Stocchi; A Agnoli
Multicenter trial of L-Deprenyl in Parkinson disease.
Italian journal of neurological sciences 1986;7(1):133-7.
1986: Fabrizio Stocchi; Stefano Ruggieri; G Brughitta; A Agnoli
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Journal of neural transmission. Supplementum 1986;22():209-18.
1986: Stefano Ruggieri; Fabrizio Stocchi; alessandro denaro; fabio baronti; A Agnoli
The role of MAO-b inhibitors in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1986;22():227-33.
1984: A Agnoli; Stefano Ruggieri; Giuseppe Meco; M Casacchia; alessandro denaro; L Conti; L Bedini; Fabrizio Stocchi; Mario Fioravanti; A Franzese
An appraisal of the problem of dementia in Parkinson's disease.
Advances in neurology 1984;40():299-306.